Business Context and Reporting Period
This Form 6-K is a report filed by InflaRx N.V., a foreign private issuer, on December 21, 2017. The filing serves to incorporate by reference exhibits containing the Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis for InflaRx GmbH for the three and nine months ended September 30, 2017.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. Revenue, profit, cash flow, margins, debt, and liquidity figures are located in the incorporated exhibits (99.1 and 99.2) and are not present in this filing text.
Material Changes
The filing text does not provide details on material changes versus prior periods. Such information is contained within the incorporated Management's Discussion and Analysis (Exhibit 99.2).
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, or contingencies are detailed in this specific document text. These disclosures are expected to be found in the incorporated exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific financial performance of InflaRx GmbH for the nine months ended September 30, 2017.
- Examine Exhibit 99.2 for management's analysis of financial condition and results of operations.
- Verify the relationship between the parent company (InflaRx N.V.) and the subsidiary (InflaRx GmbH) regarding the consolidated financial data.
- Confirm the status of the Form S-8 registration statement (No. 333-221656) referenced in the incorporation clause.